Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 25, 2018 08:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Present at NobleCon14 on January 29

PARSIPPANY, N.J. , Jan. 25, 2018 (GLOBE NEWSWIRE) -- INTERPACE DIAGNOSTICS GROUP, INC.(NASDAQ:IDXG), a fully integrated commercial and bioinformatics company that provides clinically useful...
January 08, 2018 08:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Recognized as One of the Top 20 Bioinformatics Solutions Providers

PARSIPPANY, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or the “Company”), a fully integrated commercial and bioinformatics company that...
December 18, 2017 08:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Agreement with ARUP Laboratories

PARSIPPANY, N.J., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
November 16, 2017 08:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces New York State Approval of New Product

PARSIPPANY, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Corp. (NASDAQ:IDXG), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and...
November 13, 2017 08:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Group Reports Third Quarter 2017 Financial Results, Business Progress and Recent Accomplishments

Q3-2017 Net Revenues of Over $4 Million Growing 27% Over Prior Year Quarter Represents Fourth Straight Quarter of Sequential Revenue GrowthNet Loss for the Quarter & Year to Date a 56% and 51%...
November 09, 2017 07:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results and Business Progress on Monday November 13, 2017

PARSIPPANY, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
October 25, 2017 09:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Designated as “Company of the Month” by G2 Intelligence

PARSIPPANY, N.J., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
October 23, 2017 08:45 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Presents Important Data at the World Congress of Gastroenterology at American College of Gastroenterology (ACG) 2017

PARSIPPANY, N.J., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ:IDXG), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and...
October 18, 2017 08:45 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX®/ThyraMIR®

VICTORIA, British Columbia, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides...
October 17, 2017 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Present at the Dawson James Securities 3rd Annual Small Cap Growth Stock Conference

PARSIPPANY, N.J., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) today announced that Jack Stover, the Company’s President and CEO is scheduled to present on...